An in-depth analysis of Vively and Wegovy and what weight loss option is best for you

Key Takeaways:

• Exploring the differences between Vively and Wegovy
• Evaluating the key concepts of Wegovy and how it works as a weight loss drug
• Why Vively might be the better choice for most people struggling with weight loss

Introduction

Wegovy, a prominent weight loss medication, originates from the same company as Ozempic, which has recently gained considerable attention. It stands out as the first FDA-approved weight loss drug since 2014. Containing the active compound semaglutide at a higher dosage than Ozempic, Wegovy is specifically designed to suppress appetite. Administered as a weekly injection, it aims to facilitate long-term weight management. However, it's important to note that as of now, Wegovy is not available in Australia.

Vively Health advocates for a comprehensive approach to health and well-being. By utilising their app alongside a CGM (continuous glucose monitor) included in the subscription price, users can track various lifestyle factors such as food intake, exercise, and sleep to attain peak health. Additionally, Vively serves as an educational hub, fostering a vibrant interactive community where users can exchange experiences and glean insights from others on their wellness journey. There is also the option to add on personalised dietician advice at an extra cost.

By comparing these two options, individuals can weigh the benefits of lifestyle interventions versus medication, helping them make informed decisions about their health journey based on their individual preferences and needs.

Overview of Wegovy

Wegovy is described as a long-term weight management drug, it is prescribed as a weekly injection to adults and children who struggle with obesity. Powered by its primary compound, semaglutide, Wegovy operates by curbing appetite, thereby promoting reduced food consumption and subsequent weight loss. However, it's important to note that Wegovy isn't meant to function on its own; rather, it's recommended to accompany its use with a reduction in calorie intake and an increase in physical activity for optimal results.

Wegovy’s main goal is to aid those with obesity issues, its weekly injection regimen offers a convenient solution for those finding it challenging to maintain a calorie deficit. Studies have also shown that the drug has managed to reduce the incidence of heart attack, stroke or death from heart disease by 20%.

Wegovy is targeted specifically at individuals suffering from obesity. It offers a straightforward weekly injection regimen for those struggling to maintain a calorie deficit. However, users should note that Wegovy does not provide additional weight loss guidance, necessitating seeking help elsewhere. Availability is limited, with the drug not accessible in Australia. Serious side effects include nausea, headaches, stomach pain, and the risk of developing pancreatitis. Additionally, Wegovy comes with a hefty price tag, costing $269 USD per week ($400 AUD).

Overview of Vively

Vively Health is a lifestyle app that enables individuals to analyse their glucose data and apply practical adjustments, serving individuals pursuing weight management, metabolic control, and general health improvement. It's important to mention that the Vively CGM Program isn't designed for individuals dependent on insulin for diabetes management.

Vively Health provides a comprehensive health solution by combining the Freestyle Libre 2 glucose monitor with a customised mobile application. The Vively app seamlessly integrates with various other health tracking apps such as Apple Health, Google Fit, Garmin, and more, consolidating all your health data in one convenient location. This integration aims to genuinely inspire individuals to make informed choices across all aspects of their lives. With these features, users can meticulously monitor their dietary habits, physical activity, sleep patterns, and stress levels, thereby facilitating their path towards attaining optimal wellness.

Vively is crafted to offer direct assistance to individuals striving for weight loss and tackling various health concerns. With an affordable subscription starting at $249 for three months, users gain continuous access to the app, empowering them to monitor their body's responses to food, exercise, and sleep 24/7. Every quarter, the subscription includes a Freestyle Libre 2 glucose monitor, providing additional insights into their body's reactions and aiding in personalised decision-making. Additionally, users have the option to enhance their journey with dietician support for an extra fee of $149

At present, Vively is exclusively available to users residing in Australia. Currently, the platform is solely compatible with the Continuous Glucose Monitor (CGM) Freestyle Libre 2 and does not support integration with any other CGM devices.

Direct Comparison

While Wegovy's pricing is robust and comparable to Ozempic, it's essential to note that it's not yet available in Australia. Wegovy costs around $400 per week, totaling approximately $4800 per quarter. In contrast, the Vively app, which includes the CGM, is priced at $249 quarterly. Alternatively, users can opt for an annual subscription, which includes four CGMs, priced at $996 for the entire year. Yearly subscriptions are also available at a reduced price. Additionally, access to a dietitian can be added for an extra $149 per quarter.

Similarly in our comparison to the Ozempic article, for individuals looking for a swift remedy without committing to substantial lifestyle alterations, Wegovy might seem more appealing. On the other hand, for those striving to improve their overall well-being, comprehend their body's requirements, and seek support in making informed decisions, Vively stands out as the optimal selection.

It is crucial to consider the potential long-term and short-term health effects that may arise from taking Wegovy. In contrast, Vively presents no adverse health side effects, making it a safer option for individuals concerned about their well-being.

Conclusion

Wegovy is a long-term weight management drug administered weekly via injection, containing semaglutide to curb appetite and promote weight loss. It targets both adults and children struggling with obesity, aiming to reduce heart disease risk by 20%, contingent upon lifestyle changes like diet and exercise. Not available in Australia, it may cause side effects like nausea and headaches, with a substantial weekly cost of $269 USD ($400 AUD).

On the other hand, Vively Health offers a comprehensive solution centred around glucose analysis and practical adjustments for weight management, metabolic control, and overall health enhancement. This approach integrates the Freestyle Libre 2 glucose monitor with a customised mobile app, allowing users to consolidate their health data from various tracking apps for informed decision-making. Vively aims to inspire individuals to make informed choices across all aspects of their lives. It operates on a subscription model, starting at $249 for three months, with the option to add dietician support for $149 per quarter. However, Vively Health is exclusively available in Australia and only compatible with the Freestyle Libre 2 CGM, lacking integration with other CGM devices.

When considering a weight loss program, it's vital to understand its full scope. While Wegovy is medically sanctioned, it's important to note potential side effects from its injections. Conversely, Vively places emphasis on your health and offers a safe method for overall wellness improvement. We advise consulting a healthcare professional before making a decision. If you'd like to learn more about Vively, visit our website to start your journey or engage in enriching discussions and personal stories in our community.